{"id":54562,"date":"2024-04-22T07:00:00","date_gmt":"2024-04-22T05:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-et-skyhawk-therapeutics-annoncent-la-signature-dun-accord-de-collaboration-de-recherche-visant-le-ciblage-darn-dans-les-maladies-neurologiques-rares\/"},"modified":"2024-07-23T11:53:45","modified_gmt":"2024-07-23T09:53:45","slug":"ipsen-et-skyhawk-therapeutics-annoncent-la-signature-dun-accord-de-collaboration-de-recherche-visant-le-ciblage-darn-dans-les-maladies-neurologiques-rares","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/ipsen-et-skyhawk-therapeutics-annoncent-la-signature-dun-accord-de-collaboration-de-recherche-visant-le-ciblage-darn-dans-les-maladies-neurologiques-rares\/","title":{"rendered":"Ipsen et Skyhawk Therapeutics annoncent la signature d’un accord de collaboration de recherche visant le ciblage d\u2019ARN dans les maladies neurologiques rares"},"content":{"rendered":"